Fingerprint
Dive into the research topics of 'Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis
Xavier Montalban*, Giancarlo Comi, Jack Antel, Paul O’Connor, Ana de Vera, Malika Cremer, Nikolaos Sfikas, Philipp von Rosenstiel, Ludwig Kappos
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
16
Citations
(Scopus)